Good news from the science front – MSNBC – Montezuma’s curse gets reversed.

September issue, Budget Travel magazine – Traveler’s diarrhea, or T.D., has ruined many a vacation, especially to high-risk destinations such as Mexico and India.

Changing the approach to treating the common ailment is an antibiotic that’ss newly approved in the U.S., but one that’s been prescribed in Europe for years. Rifaximin was given the official OK by the FDA this past spring, and as of August it’ll be sold under the name Xifaxan (the first x is pronounced like a z).